Skip to content

Xander Lens: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Xander Lens

BE 1011.201.739
NACE 86.951, Physiotherapy
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€42,739
2024 · €12,188+€30,551
Equity
€57,926
2024 · €15,188+€42,739
Cash
€45,525
2024 · €9,415+€36,110
Balance sheet total
€59,135
2024 · €15,248+€43,887

Largest movements

2024 to 2025
Assets
  • Cash +€36,110

    up €36,110 (+384%), from €9,415 to €45,525

    mainly Net result for the year (+€42,739) and Trade debts (+€1,209)

  • Deferred charges and accrued income +€5,410

    up €5,410 (+108%), from €5,014 to €10,424

  • Receivables within one year +€1,868

    up €1,868 (+228%), from €819 to €2,686

    of which Other amounts receivable: +€2,686

Equity and liabilities
  • Profit (loss) carried forward +€42,739

    up €42,739 (+351%), from €12,188 to €54,926

  • Trade debts +€1,209

    new in 2025: €1,209

Income statement
  • Gross operating margin +€37,553

    up €37,553 (+230%), from €16,353 to €53,906

  • Taxes +€7,882

    up €7,882 (+263%), from €3,000 to €10,882

  • Depreciation -€1,093

    no longer reported in 2025 (was €1,093)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €12,188
Gross operating margin +€37,553
Depreciation +€1,093
Other operating charges -€190
Financial charges -€23
Taxes -€7,882
Result 2025 €42,739
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€36,610
Investment -€500
Financing €0
Cash 2024 €9,415
Net result for the year +€42,739
Receivables within one year -€1,868
Deferred charges and accrued income -€5,410
Trade debts +€1,209
Other debts -€61
Current investments -€500
Cash 2025 €45,525
brings cash intakes cash out
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €15,248 €59,135 +€43,887 +288%
Current assets 29/58 €15,248 €59,135 +€43,887 +288%
Amounts receivable within one year 40/41 €819 €2,686 +€1,868 +228%
Trade receivables 40 €819 - -€819
Other amounts receivable 41 - €2,686 +€2,686
Current investments 50/53 - €500 +€500
Cash at bank and in hand 54/58 €9,415 €45,525 +€36,110 +384%
Deferred charges and accrued income 490/1 €5,014 €10,424 +€5,410 +108%
Total equity and liabilities 10/49 €15,248 €59,135 +€43,887 +288%
Equity 10/15 €15,188 €57,926 +€42,739 +281%
Contributions 10/11 €3,000 €3,000 = 0.0%
Profit (loss) carried forward 14 €12,188 €54,926 +€42,739 +351%
Amounts payable 17/49 €61 €1,209 +€1,148 +1,891%
Amounts payable within one year 42/48 €61 €1,209 +€1,148 +1,891%
Trade debts 44 - €1,209 +€1,209
Suppliers 440/4 - €1,209 +€1,209
Other amounts payable 47/48 €61 - -€61
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,093 - -€1,093
Other operating charges 640/8 €50 €240 +€190 +380%
Gross operating margin 9900 €16,353 €53,906 +€37,553 +230%
Operating profit (loss) 9901 €15,210 €53,666 +€38,456 +253%
Financial charges 65/66B €23 €45 +€23 +100%
Recurring financial charges 65 €23 €45 +€23 +100%
Profit (loss) for the period before taxes 9903 €15,188 €53,621 +€38,433 +253%
Income taxes 67/77 €3,000 €10,882 +€7,882 +263%
Profit (loss) for the period 9904 €12,188 €42,739 +€30,551 +251%
Profit (loss) for the period to be appropriated 9905 €12,188 €42,739 +€30,551 +251%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.